# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-19-032869
Filing Date
2019-06-28
Accepted
2019-06-28 08:00:29
Documents
10
Period of Report
2019-07-30
Effectiveness Date
2019-06-28

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tv524043_def14a.htm | DEF 14A | 828536
2 | GRAPHIC | tv524043_img1.jpg | GRAPHIC | 3866
3 | GRAPHIC | tv524043_img2.jpg | GRAPHIC | 1855
4 | GRAPHIC | tv524043_img3.jpg | GRAPHIC | 45218
5 | GRAPHIC | tv524043_img4.jpg | GRAPHIC | 27251
6 | GRAPHIC | tv524043_img5.jpg | GRAPHIC | 50106
7 | GRAPHIC | tv524043_img6.jpg | GRAPHIC | 3093
8 | GRAPHIC | tv524043_img7.jpg | GRAPHIC | 259850
9 | GRAPHIC | tv524043_img8.jpg | GRAPHIC | 329484
10 | GRAPHIC | tv524043_img9.jpg | GRAPHIC | 204579
| Complete submission text file | 0001144204-19-032869.txt |  | 2105310

Mailing Address 660 WHITE PLAINS RD. TARRYTOWN NY 10591
Business Address 660 WHITE PLAINS RD. TARRYTOWN NY 10591 (914) 524-6800
Prestige Consumer Healthcare Inc. (Filer) CIK: 0001295947 (see all company filings)

EIN.: 201297589 | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-32433 | Film No.: 19927334
SIC: 2834 Pharmaceutical Preparations